Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Clinical trial NCT04504331 · TERMINATED
Trial details
- NCT number
- NCT04504331
- Sponsor
- Jennifer Lee Caswell-Jin
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2021-10-22
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.